is naltrexone a glp 1 drug Comparing Ozempic, Wegovy and Other GLP-1 Drugs Obesity drugs under review: Semaglutide,

10.1016/j.neuropharm.2023.109716 Neuropharmacology 70 WongC

Statements Data availability statement The original contributions presented in the study are included in the article/ Supplementary Materials , further inquiries can be directed to the corresponding author/s

Status: Recruiting Double-blinded randomized clinical trial investigating the effects of subcutaneous semaglutide vs placebo on alcohol consumption in 108 patients diagnosed with alcohol use disorder and comorbid obesity over a 26-week period

After Ozempic, the market is moving toward obesity-specific injectables, oral GLP-1 drugs, dual agonists, triple agonists, amylin combinations, and cardiometabolic platform therapies

doi: 10.1186/s12888-025-06914-0

For patients who want the security of an FDA-approved medication with insurance coverage, PlushCare is the opposite end of the spectrum from MedVi's compounded, cash-pay model